Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted August 20, 2013
Weight Loss Supplement Formulas For Men and Women Recalled Due To Undeclared Drugs
Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.
These supplements were sold nationwide through internet and retail sales.
Esbelder man contains acai, wolfberry, green tea, Cha de Bugre, resveratrol and L-carnitine, and is promoted for men's weight loss, increased energy and lower cholesterol. It is packaged in white plastic bottles containing 30 capsules, and can be identified by UPC 7502011000275.
Esbelder fem contains artichoke, Camellia sinensis, black cohosh, mangosteen, spirulina, Hippocratea excels, Cassia angustifolia, tofu and L-carnitine, and is promoted for fat loss, lowering cholesterol and improving menstrual symptoms. It is packaged in white plastic bottles containing 30 capsules, and can be identified by UPC 7502011000251.
Esbelder Siloutte contains goji, acai, mangosteen, Camellia sinensis, Cha de Bugre, Garcinia cambogia and L- carnitine. It is packaged in white plastic bottles containing 30 capsules, and can be identified by UPC 7502011000268.
(See ConsumerLab.com's Reviews of Weight Loss Supplements, Energy Supplements and Cholesterol-Lowering Supplements for tests of related products and see Reviews of Green Tea Supplements, Black Cohosh Supplements, Acetyl-L-Carnitine Supplements, Mangosteen Supplements and Acai Supplements for more information about these ingredients.)
Consumers who have purchased these supplements should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.
See Related Warnings
For more information about this recall, use the link below.